99,237 Shares in OrthoPediatrics Corp. (NASDAQ:KIDS) Bought by Kennedy Capital Management LLC

Kennedy Capital Management LLC acquired a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 99,237 shares of the company’s stock, valued at approximately $2,894,000.

Other hedge funds have also bought and sold shares of the company. EntryPoint Capital LLC raised its stake in OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after buying an additional 1,009 shares during the period. Vanguard Group Inc. lifted its holdings in OrthoPediatrics by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock valued at $25,772,000 after purchasing an additional 11,100 shares during the last quarter. State Board of Administration of Florida Retirement System bought a new position in OrthoPediatrics during the first quarter worth $178,000. Quantbot Technologies LP raised its position in shares of OrthoPediatrics by 180.8% in the first quarter. Quantbot Technologies LP now owns 7,091 shares of the company’s stock valued at $207,000 after purchasing an additional 4,566 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in shares of OrthoPediatrics by 85.1% during the 1st quarter. BNP Paribas Financial Markets now owns 12,414 shares of the company’s stock worth $362,000 after buying an additional 5,707 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

KIDS has been the topic of a number of research reports. JMP Securities reiterated a “market outperform” rating and issued a $50.00 price target on shares of OrthoPediatrics in a research note on Tuesday, May 7th. Truist Financial dropped their target price on shares of OrthoPediatrics from $38.00 to $35.00 and set a “hold” rating for the company in a report on Tuesday, July 16th. Finally, Needham & Company LLC lifted their price target on shares of OrthoPediatrics from $37.00 to $42.00 and gave the company a “buy” rating in a report on Tuesday, May 7th.

OrthoPediatrics Price Performance

KIDS stock traded down $0.40 during midday trading on Wednesday, reaching $31.85. 22,691 shares of the stock were exchanged, compared to its average volume of 162,585. OrthoPediatrics Corp. has a 52 week low of $23.10 and a 52 week high of $42.07. The company has a fifty day moving average price of $31.36 and a 200 day moving average price of $29.75. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99. The stock has a market capitalization of $758.99 million, a PE ratio of -33.59 and a beta of 1.19.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Monday, May 6th. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.12. The firm had revenue of $44.69 million for the quarter, compared to analyst estimates of $41.63 million. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. As a group, analysts expect that OrthoPediatrics Corp. will post -1.2 EPS for the current fiscal year.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.